Tag: Precedence Research
ASX biotech firm Noxopharm’s new mRNA enhancer to make vaccines safer
Australian biotech company Noxopharm Limited unveiled today the development of a new mRNA vaccine enhancer that will make mRNA vaccines safer by reducing inflammation associated with mRNA vaccines.
Report: 3D printers market size to reach USD 88.61b by 2032
The market for 3D printers will be worth approximately USD 88.61 billion by 2032 and will grow at a CAGR of 17.54 per cent between 2023 and 2032, according to a recent report by Precedence Research.
Featured Article
How AI-enabled cloud ERP is redefining growth for manufacturing leaders
Manufacturing leaders are entering a new phase of supply chain transformation, where growth is increasingly determined by how quickly and intelligently organisations can respond to change.
